dc.creatorGarbuzova-Davis, Svitlana
dc.creatorHernandez-Ontiveros, Diana G.
dc.creatorRodrigues, Maria C. O.
dc.creatorHaller, Edward
dc.creatorFrisina-Deyo, Aric
dc.creatorMirtyl, Santhia
dc.creatorSallot, Sebastian
dc.creatorSaporta, Samuel
dc.creatorBorlongan, Cesario V.
dc.creatorSanberg, Paul R.
dc.date.accessioned2013-10-31T11:36:18Z
dc.date.accessioned2018-07-04T16:07:19Z
dc.date.available2013-10-31T11:36:18Z
dc.date.available2018-07-04T16:07:19Z
dc.date.created2013-10-31T11:36:18Z
dc.date.issued2013-08-02
dc.identifierBRAIN RESEARCH, AMSTERDAM, v. 1469, n. 1, supl. 1, Part 6, pp. 114-128, AUG 21, 2012
dc.identifier0006-8993
dc.identifierhttp://www.producao.usp.br/handle/BDPI/37113
dc.identifier10.1016/j.brainres.2012.05.056
dc.identifierhttp://dx.doi.org/10.1016/j.brainres.2012.05.056
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1631704
dc.description.abstractVascular pathology, including blood-brain/spinal cord barrier (BBB/BSCB) alterations, has recently been recognized as a key factor possibly aggravating motor neuron damage, identifying a neurovascular disease signature for ALS. However, BBB/BSCB competence in sporadic ALS (SALS) is still undetermined. In this study, BBB/BSCB integrity in postmortem gray and white matter of medulla and spinal cord tissue from SALS patients and controls was investigated. Major findings include (1) endothelial cell damage and pericyte degeneration, (2) severe intra- and extracellular edema, (3) reduced CD31 and CD105 expressions in endothelium, (4) significant accumulation of perivascular collagen IV, and fibrin deposits (5) significantly increased microvascular density in lumbar spinal cord, (6) IgG microvascular leakage, (7) reduced tight junction and adhesion protein expressions. Microvascular barrier abnormalities determined in gray and white matter of the medulla, cervical, and lumbar spinal cord of SALS patients are novel findings. Pervasive barrier damage discovered in ALS may have implications for disease pathogenesis and progression, as well as for uncovering novel therapeutic targets. (C) 2012 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherELSEVIER SCIENCE BV
dc.publisherAMSTERDAM
dc.relationBRAIN RESEARCH
dc.rightsCopyright ELSEVIER SCIENCE BV
dc.rightsclosedAccess
dc.subjectAMYOTROPHIC LATERAL SCLEROSIS
dc.subjectPATIENTS
dc.subjectBLOOD-BRAIN/SPINAL CORD BARRIER
dc.subjectIMPAIRMENT
dc.titleImpaired blood-brain/spinal cord barrier in ALS patients
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución